Related Experiment Video
Updated: Oct 24, 2025

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Monocyte-to-HDL-cholesterol ratio is associated with Ascending Aorta Dilatation in Patients with Bicuspid Aortic
Burak Acar1, Cagrı Yayla2, Murat Gul3
1Department of Cardiology, Faculty of Medicine, Kocaeli University, Kocaeli/Turkey.
Insights
The monocyte count-to-HDL-cholesterol ratio (MHR) is elevated in patients with bicuspid aortic valve and aortic dilatation. This ratio, along with uric acid, is independently associated with aortic dilatation in this patient group.
Area of Science:
- Cardiology
- Biomarkers
- Genetics
Background:
- The monocyte count-to-HDL-cholesterol ratio (MHR) is a recognized marker in cardiovascular diseases.
- Ascending aortic dilatation (AAD) is a frequent complication in individuals with bicuspid aortic valve (BAV).
Purpose of the Study:
- To investigate the association between MHR and the presence of aortic dilatation in patients diagnosed with BAV.
Main Methods:
- A cohort of 347 patients with BAV was analyzed.
- Patients were categorized into two groups: those with AAD (ascending aorta diameter ≥ 4.0 cm) and those without.
- Echocardiographic and laboratory data were collected and compared between groups.
Main Results:
- MHR was significantly higher in patients with aortic dilatation compared to those without.
- MHR and uric acid levels were independently correlated with the presence of aortic dilatation in the BAV cohort.
Conclusions:
- A significant relationship exists between MHR and aortic dilatation in patients with BAV.
Background:
The importance of monocyte count-to-HDL-cholesterol ratio (MHR) in cardio- vascular diseases has been shown in various studies. Ascending aortic dilatation (AAD) is a common complication in the patients with bicuspid aortic valve. In this study, we aimed to investigate the relationship between MHR and the presence of aortic dilatation in the patients with bicuspid aortic valve.
Methods:
The study population included totally 347 patients with bicuspid aortic valve.169 patients with aortic dilatation (ascending aorta diameter ≥ 4.0 cm) and 178 patients with no aortic dilatation. Echocardiographic and laboratory measurement was done and compared between groups.
Results:
The mean age of the participants was 44.7 ± 15.4 years and average ascending aorta diameter was 3.2 ± 0.3 cm in dilatation negative group and 4.4 ± 0.4 cm in positive group. MHR was significantly increased in in patients with aortic dilatation. MHR and uric acid level was independently associated with the presence of aortic dilatation in the patients with bicuspid aortic valve.
Conclusion:
We found a significant relationship between MHR and aortic dilatation in the patients with bicuspid aortic valve.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction

